Immune checkpoint inhibitor-related dermatologic adverse events are skin-related side effects that occur when immune checkpoint inhibitors, a type of cancer immunotherapy, cause the immune system to attack healthy skin cells. These events can range from mild rashes to severe conditions like Stevens-Johnson syndrome, and their management often requires balancing effective cancer treatment with minimizing skin toxicity.